Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications vary in th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Health Serv Res
Main Authors: Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Davies, Evan W., Paczkowski, Rosirene
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5702146/
https://ncbi.nlm.nih.gov/pubmed/29178918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2648-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker